Patients' views of consent in clinical trials for acute myocardial infarction: impact of trial design

Objective Seeking prospective informed consent is difficult in clinical trials for emergent conditions such as acute myocardial infarction (AMI). Prior data suggest that enrolment decisions of patients are often poorly informed in AMI trials but that patients prefer to be asked permission before enr...

Full description

Saved in:  
Bibliographic Details
Authors: Dickert, W. (Author) ; Hendershot, A. (Author) ; Speight, D. (Author) ; Fehr, E. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2017
In: Journal of medical ethics
Year: 2017, Volume: 43, Issue: 8, Pages: 524-529
Online Access: Volltext (JSTOR)
Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 1816156094
003 DE-627
005 20230426115900.0
007 cr uuu---uuuuu
008 220908s2017 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2016-103866  |2 doi 
035 |a (DE-627)1816156094 
035 |a (DE-599)KXP1816156094 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Dickert, W.  |e VerfasserIn  |4 aut 
245 1 0 |a Patients' views of consent in clinical trials for acute myocardial infarction: impact of trial design 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Objective Seeking prospective informed consent is difficult in clinical trials for emergent conditions such as acute myocardial infarction (AMI). Prior data suggest that enrolment decisions of patients are often poorly informed in AMI trials but that patients prefer to be asked permission before enrolment. It is unknown whether this is true across trial designs or in comparative effectiveness research (CER) with approved treatments.Methods Structured interviews were conducted with 30 patients with AMI. Participants considered three scenarios: (1) a CER trial of approved antiplatelet drugs; (2) a placebo-controlled trial of a novel drug to reduce myocardial injury and (3) a CER trial of an intra-aortic balloon pump versus medication. Participants were asked their desired involvement in enrolment decisions and willingness to participate. Descriptive analysis was performed of Likert scale data, and qualitative descriptive analysis was performed of textual data.Results Across scenarios, most participants (73%-80%) preferred to be asked permission prior to trial enrolment. Reasons for involvement included wanting to be the decision maker and a desire for transparency. Willingness to enrol was affected by trial type. Fewer participants stated they would likely enrol in a CER procedural trial than in a CER trial of approved medications (p=0.012).Conclusions These findings suggest that patients prefer prospective involvement in enrolment decisions to enrolment without consent across trial types. However, their desire to participate was affected by trial type. There is a need to develop and evaluate context-sensitive approaches to consent in AMI trials that account for both the acuity of the situation and trial characteristics. 
601 |a Patient 
700 1 |a Hendershot, A.  |e VerfasserIn  |4 aut 
700 1 |a Speight, D.  |e VerfasserIn  |4 aut 
700 1 |a Fehr, E.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 43(2017), 8, Seite 524-529  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:43  |g year:2017  |g number:8  |g pages:524-529 
856 |3 Volltext  |u http://www.jstor.org/stable/44606616  |x JSTOR 
856 4 0 |u https://doi.org/10.1136/medethics-2016-103866  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/43/8/524.abstract  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
936 u w |d 43  |j 2017  |e 8  |h 524-529 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185610033 
LOK |0 003 DE-627 
LOK |0 004 1816156094 
LOK |0 005 20220908053711 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-03#6AF0E459F070A790B9A736F2F278439B9ACD7590 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/44606616 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1  |b inherited from superior work 
ORI |a SA-MARC-ixtheoa001.raw